CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-28 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −3,924 | $0.65 | $3K | 882,811 |
| 2026-03-24 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −36,418 | $0.69 | $25K | 886,735 |
| 2026-03-18 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −8,072 | $0.63 | $5K | 923,153 |
| 2026-03-16 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +200,000 | 931,225 | ||
| 2026-03-16 | Tucker Sean SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2026-02-02 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −9,265 | $0.61 | $6K | 731,225 |
| 2025-03-28 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −3,913 | $0.42 | $2K | 740,490 |
| 2025-03-24 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +406,000 | 744,403 | ||
| 2025-03-24 | Tucker Sean SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +610,000 | 610,000 | ||
| 2025-03-18 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −8,050 | $0.57 | $5K | 338,403 |
| 2025-02-02 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −9,242 | $0.68 | $6K | 346,453 |
| 2024-03-28 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −3,902 | $1.30 | $5K | 355,695 |
| 2024-03-18 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +90,000 | 420,122 | ||
| 2024-03-18 | Tucker Sean SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2024-02-02 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −9,220 | $1.20 | $11K | 330,122 |
| 2023-12-08 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −34,288 | $0.71 | $24K | 339,342 |
| 2023-03-28 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −3,683 | $0.75 | $3K | 373,630 |
| 2023-03-17 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +45,000 | 172,631 | ||
| 2023-03-17 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +54,157 | 226,788 | ||
| 2023-03-17 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +90,000 | 316,788 |
Page 1 of 3 · 52 trades